"Injection: 2 mg/3 mL (0.68 mg/mL) available in: •Single-patient-use pen that delivers 0.25 mg or 0.5 mg per injection (3) Injection: 2 mg/1.5 mL (1.34 mg/mL) available in: •Single-patient-use pen that delivers 0.25 mg or 0.5 mg per injection. Injection: 4 mg/3 mL (1.34 mg/mL) available in: •Single-patient-use pen that delivers 1 mg per injection. Injection: 8 mg/3 mL (2.68 mg/mL) available in: •Single-patient-use pen that delivers 2 mg per injection."

"•Start at 0.25 mg once weekly. After 4 weeks, increase the dose to 0.5 mg once weekly. • If additional glycaemic control is needed, increase the dose to 1 mg once weekly after at least 4 weeks on the 0.5 mg dose. • If additional glycaemic control is needed, increase the dose to 2 mg once weekly after at least 4 weeks on the 1 mg dose. •Administer once weekly at any time of day, with or without meals. •If a dose is missed administer within 5 days of missed dose. •Inject subcutaneously in the abdomen, thigh, or upper arm (2.2"

•An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. •To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.